^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    KRAS-EphA-2-CAR-DC

    i
    Associations
    News
    Trials
    Company:
    Chinese PLA General Hospital
    Drug class:
    Dendritic cell activator, EphA2 inhibitor
    Related drugs:
    Associations
    News
    Trials